Jee H Lee1, Le Zou2, Runqing Yang3, Jihye Han4, Qingqing Wan2, Xian Zhang3, Sarah El Baghdady4, Andrea Roman4, Chris Elly4, Hyung-Seung Jin5, Yoon Park6, Michael Croft7, Yun-Cai Liu8. 1. Division of Cell Biology, La Jolla Institute for Immunology, La Jolla, Calif; Division of Immune Regulation, La Jolla Institute for Immunology, La Jolla, Calif. Electronic address: jhlee@lji.org. 2. Division of Cell Biology, La Jolla Institute for Immunology, La Jolla, Calif; Institute for Immunology, Tsinghua-Peking Center for Life Sciences, School of Medicine, Tsinghua University, Beijing, China. 3. Institute for Immunology, Tsinghua-Peking Center for Life Sciences, School of Medicine, Tsinghua University, Beijing, China. 4. Division of Cell Biology, La Jolla Institute for Immunology, La Jolla, Calif. 5. Division of Cell Biology, La Jolla Institute for Immunology, La Jolla, Calif; Department of Convergence Medicine, ASAN Institute for Life Sciences, ASAN Medical Center, University of Ulsan College of Medicine, Seoul, Korea. 6. Division of Cell Biology, La Jolla Institute for Immunology, La Jolla, Calif; Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul, Korea. 7. Division of Immune Regulation, La Jolla Institute for Immunology, La Jolla, Calif. 8. Division of Cell Biology, La Jolla Institute for Immunology, La Jolla, Calif; Institute for Immunology, Tsinghua-Peking Center for Life Sciences, School of Medicine, Tsinghua University, Beijing, China. Electronic address: yuncail@hotmail.com.
Abstract
BACKGROUND: Type 2 immunity can be modulated by regulatory T (Treg) cell activity. It has been suggested that the deubiquitinase cylindromatosis (CYLD) plays a role in the development or function of Treg cells, implying that it could be important for normal protective immunity, where type 2 responses are prevalent. OBJECTIVE: We sought to investigate the role of CYLD in Treg cell function and TH2 cell immune responses under steady-state conditions and during helminth infection. METHODS: Foxp3-restricted CYLD conditional knockout (KO) mice were examined in mouse models of allergen-induced airway inflammation and Nippostrongylus brasiliensis infection. We performed multiplex magnetic bead assays, flow cytometry, and quantitative PCR to understand how a lack of CYLD affected cytokine production, homing, and suppression in Treg cells. Target genes regulated by CYLD were identified and validated by microarray analysis, coimmunoprecipitation, short hairpin RNA knockdown, and transfection assays. RESULTS: Treg cell-specific CYLD KO mice showed severe spontaneous pulmonary inflammation with increased migration of Treg cells into the lung. CYLD-deficient Treg cells furthermore produced high levels of IL-4 and failed to suppress allergen-induced lung inflammation. Supporting this, the conditional KO mice displayed enhanced protection against N brasiliensis infection by contributing to type 2 immunity. Treg cell conversion into IL-4-producing cells was due to augmented mitogen-activated protein kinase and nuclear factor κB signaling. Moreover, Scinderin, a member of the actin-binding gelsolin family, was highly upregulated in CYLD-deficient Treg cells, and controlled IL-4 production through forming complexes with mitogen-activated protein kinase kinase/extracellular receptor kinase. Correspondingly, both excessive IL-4 production in vivo and the protective role of CYLD-deficient Treg cells against N brasiliensis were reversed by Scinderin ablation. CONCLUSIONS: Our findings indicate that CYLD controls type 2 immune responses by regulating Treg cell conversion into TH2 cell-like effector cells, which potentiates parasite resistance.
BACKGROUND: Type 2 immunity can be modulated by regulatory T (Treg) cell activity. It has been suggested that the deubiquitinase cylindromatosis (CYLD) plays a role in the development or function of Treg cells, implying that it could be important for normal protective immunity, where type 2 responses are prevalent. OBJECTIVE: We sought to investigate the role of CYLD in Treg cell function and TH2 cell immune responses under steady-state conditions and during helminth infection. METHODS: Foxp3-restricted CYLD conditional knockout (KO) mice were examined in mouse models of allergen-induced airway inflammation and Nippostrongylus brasiliensis infection. We performed multiplex magnetic bead assays, flow cytometry, and quantitative PCR to understand how a lack of CYLD affected cytokine production, homing, and suppression in Treg cells. Target genes regulated by CYLD were identified and validated by microarray analysis, coimmunoprecipitation, short hairpin RNA knockdown, and transfection assays. RESULTS: Treg cell-specific CYLD KO mice showed severe spontaneous pulmonary inflammation with increased migration of Treg cells into the lung. CYLD-deficient Treg cells furthermore produced high levels of IL-4 and failed to suppress allergen-induced lung inflammation. Supporting this, the conditional KO mice displayed enhanced protection against N brasiliensis infection by contributing to type 2 immunity. Treg cell conversion into IL-4-producing cells was due to augmented mitogen-activated protein kinase and nuclear factor κB signaling. Moreover, Scinderin, a member of the actin-binding gelsolin family, was highly upregulated in CYLD-deficient Treg cells, and controlled IL-4 production through forming complexes with mitogen-activated protein kinase kinase/extracellular receptor kinase. Correspondingly, both excessive IL-4 production in vivo and the protective role of CYLD-deficient Treg cells against N brasiliensis were reversed by Scinderin ablation. CONCLUSIONS: Our findings indicate that CYLD controls type 2 immune responses by regulating Treg cell conversion into TH2 cell-like effector cells, which potentiates parasite resistance.
Authors: Yuri P Rubtsov; Jeffrey P Rasmussen; Emil Y Chi; Jason Fontenot; Luca Castelli; Xin Ye; Piper Treuting; Lisa Siewe; Axel Roers; William R Henderson; Werner Muller; Alexander Y Rudensky Journal: Immunity Date: 2008-04 Impact factor: 31.745
Authors: Fabian Flores-Borja; Elizabeth C Jury; Claudia Mauri; Michael R Ehrenstein Journal: Proc Natl Acad Sci U S A Date: 2008-11-26 Impact factor: 11.205
Authors: Julius A Potian; Wasiulla Rafi; Kamlesh Bhatt; Amanda McBride; William C Gause; Padmini Salgame Journal: J Exp Med Date: 2011-08-08 Impact factor: 14.307
Authors: Christopher J Oliphant; You Yi Hwang; Jennifer A Walker; Maryam Salimi; See Heng Wong; James M Brewer; Alexandros Englezakis; Jillian L Barlow; Emily Hams; Seth T Scanlon; Graham S Ogg; Padraic G Fallon; Andrew N J McKenzie Journal: Immunity Date: 2014-07-31 Impact factor: 31.745
Authors: Timotheus Y F Halim; Batika M J Rana; Jennifer A Walker; Bernhard Kerscher; Martin D Knolle; Helen E Jolin; Eva M Serrao; Liora Haim-Vilmovsky; Sarah A Teichmann; Hans-Reimer Rodewald; Marina Botto; Timothy J Vyse; Padraic G Fallon; Zhi Li; David R Withers; Andrew N J McKenzie Journal: Immunity Date: 2018-06-12 Impact factor: 43.474